Company Profile
Leadgene Co., Ltd is a prominent chemical company headquartered in South Korea. Since its establishment in 1991, the company has experienced substantial growth by focusing on the research, development, and production of a diverse range of chemical products and materials for various industries. Leadgene's unwavering commitment to innovation, quality, and customer satisfaction has been instrumental in its success.
Leadgene's comprehensive product portfolio encompasses pharmaceuticals, cosmetics, home care, and industrial chemicals. The company's cutting-edge manufacturing facilities and expertise in research and development enable the creation of high-quality products that cater to the specific needs of its customers.
Beyond its core business, Leadgene actively engages in collaborative research and development projects with universities and research institutes. The company's ultimate objective is to develop new and groundbreaking products that can address future challenges and contribute to a sustainable and improved world.
Leadgene's dedication to quality, innovation, and customer satisfaction has earned it a solid reputation as a trusted partner for numerous businesses and organizations worldwide. Additionally, the company's unwavering commitment to sustainability and social responsibility has garnered various awards and accolades, including the prestigious Presidential Commendation for Industry and Technology.
VIEW MORE VIEW LESS
Product List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Azosemide |
Benzenesulfonamide,2-chloro-5-(2H-tetrazol-5-yl)-4-[(2-thienylmethyl)amino]-;Sulfanilamide,2-chloro-5-(1H-tetrazol-5-yl)-N4-2-thenyl-;Benzenesulfonamide,2-chloro-5-(1H-tetrazol-5-yl)-4-[(2-thienylmethyl)amino]-;2-Chloro-5-(2H-tetrazol-5-yl)-4-[(2-thienylmethyl)amino]benzenesulfonamide;5-(4-Chloro-5-sulfamoyl-2-thenylaminophenyl)tetrazole;Ple 1053;Azosemide;2-Chloro-5-(1H-tetrazol-5-yl)-4-[(2-thienylmethyl)amino]benzenesulfonamide;SK 110 (pharmaceutical);SK 110;Luret;Diart;Diurapid;2-Chloro-5-(2H-tetrazol-5-yl)-4-(thiophen-2-ylmethylamino)benzenesulfonamide |
27589-33-9 | Inquiry | |
Cefotiam |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[2-(2-amino-4-thiazolyl)acetyl]amino]-3-[[[1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl]thio]methyl]-8-oxo-,(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2-amino-4-thiazolyl)acetyl]amino]-3-[[[1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl]thio]methyl]-8-oxo-,(6R-trans)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2-amino-4-thiazolyl)acetyl]amino]-3-[[[1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl]thio]methyl]-8-oxo-,(6R,7R)-;(6R,7R)-7-[[2-(2-Amino-4-thiazolyl)acetyl]amino]-3-[[[1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;SCE 963;Cefotiam;CGP 14221E;67356-92-7;70896-40-1 |
61622-34-2 | Inquiry | |
Cinepazide |
2-Propen-1-one,1-[4-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1-piperazinyl]-3-(3,4,5-trimethoxyphenyl)-;Piperazine,1-[(1-pyrrolidinylcarbonyl)methyl]-4-(3,4,5-trimethoxycinnamoyl)-;Piperazine,1-[2-oxo-2-(1-pyrrolidinyl)ethyl]-4-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-;1-[4-[2-Oxo-2-(1-pyrrolidinyl)ethyl]-1-piperazinyl]-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one;Cinepazide;47658-44-6 |
23887-46-9 | Inquiry | |
Suplatast tosilate |
Sulfonium,[3-[[4-(3-ethoxy-2-hydroxypropoxy)phenyl]amino]-3-oxopropyl]dimethyl-,4-methylbenzenesulfonate (1:1);Sulfonium,[3-[[4-(3-ethoxy-2-hydroxypropoxy)phenyl]amino]-3-oxopropyl]dimethyl-,salt with 4-methylbenzenesulfonic acid (1:1);Suplatast tosilate;Suplatast tosylate;IPD 1151T;[2-[4-(3-Ethoxy-2-hydroxypropoxy)phenylcarbamoyl]ethyl]dimethylsulfonium p-toluenesulfonate;(±)-[2-[4-(3-Ethoxy-2-hydroxypropoxy)phenylcarbamoyl]ethyl]dimethylsulfonium p-toluenesulfonate;160114-29-4;1776086-79-3 |
94055-76-2 | Inquiry |